Literature DB >> 27172303

Histamine 2 Receptor Antagonists and Proton Pump Inhibitors.

Megan D Brinkworth1, Mouhammad Aouthmany, Michael Sheehan.   

Abstract

Within the last 50 years, the pharmacologic market for gastric disease has grown exponentially. Currently, medical management with histamine 2 receptor antagonist and proton pump inhibitors are the mainstay of therapy over surgical intervention. These are generally regarded as safe medications, but there are growing numbers of cases documenting adverse effects, especially those manifesting in the skin. Here we review the pharmacology, common clinical applications, and adverse reactions of both histamine 2 receptor antagonists and proton pump inhibitors with a particular focus on the potential for allergic reactions including allergic contact dermatitis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27172303     DOI: 10.1097/DER.0000000000000172

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  1 in total

1.  Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.

Authors:  Lu Liu; Yongqi Yu; Qingze Fan; Zhigui Wu; Xiuying Li; Hongli Luo
Journal:  BMC Health Serv Res       Date:  2022-03-29       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.